{"id":5567,"date":"2024-09-13T17:53:30","date_gmt":"2024-09-13T17:53:30","guid":{"rendered":"https:\/\/regtechafrica.com\/healthcare\/?p=5567"},"modified":"2024-09-13T17:58:19","modified_gmt":"2024-09-13T17:58:19","slug":"global-teva-bracing-for-eu-fine-over-rival-multiple-sclerosis-drug-disparagement","status":"publish","type":"post","link":"https:\/\/regtechafrica.com\/healthcare\/global-teva-bracing-for-eu-fine-over-rival-multiple-sclerosis-drug-disparagement\/","title":{"rendered":"Global: Teva Bracing for EU Fine Over Rival Multiple Sclerosis Drug Disparagement"},"content":{"rendered":"<p>Teva Pharmaceutical Industries Ltd. the world&#8217;s largest generic drug manufacturer, is expected to face an EU antitrust fine in the coming weeks for allegedly disparaging a competitor&#8217;s multiple sclerosis treatment, according to sources familiar with the situation.<\/p>\n<p>In 2022, the European Commission charged Teva with violating EU antitrust regulations, claiming the company engaged in anti-competitive practices, including the misuse of the patent system to unjustly prolong the patent for its flagship multiple sclerosis drug, Copaxone, thereby shielding it from competition.<\/p>\n<p>The European Commission&#8217;s stringent stance reflects its concerns that such practices may hinder innovation within the pharmaceutical sector, particularly in light of the financial constraints faced by healthcare systems across Europe.<\/p>\n<p>While the Commission has refrained from commenting on the ongoing case, Teva has yet to respond to requests for further information.<\/p>\n<p>This investigation has a lengthy history, beginning with EU dawn raids in 2019 that eventually led to a formal inquiry in 2021.<\/p>\n<p>Companies found guilty of breaching EU antitrust laws can face fines of up to 10% of their global annual revenue, although such penalties are not frequently imposed at the maximum level.<\/p>\n<p>In 2020, Teva and its subsidiary, Cephalon, were fined \u20ac60.5 million (approximately $66.7 million) for entering into an agreement to delay the release of a cheaper generic version of Cephalon&#8217;s sleep disorder medication. This penalty was part of the EU&#8217;s broader crackdown on pay-for-delay arrangements between brand-name pharmaceutical companies and their generic competitors.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Teva Pharmaceutical Industries Ltd. the world&#8217;s largest generic drug manufacturer, is expected to face an EU antitrust fine in the coming weeks for allegedly disparaging a competitor&#8217;s multiple sclerosis treatment,&hellip;<\/p>\n","protected":false},"author":1,"featured_media":5571,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[78],"tags":[],"class_list":["post-5567","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-regulatory"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/regtechafrica.com\/healthcare\/wp-content\/uploads\/2024\/09\/24apple-eu1-gqch-articleLarge.jpg.webp?fit=600%2C418&ssl=1","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/posts\/5567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/comments?post=5567"}],"version-history":[{"count":1,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/posts\/5567\/revisions"}],"predecessor-version":[{"id":5569,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/posts\/5567\/revisions\/5569"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/media\/5571"}],"wp:attachment":[{"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/media?parent=5567"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/categories?post=5567"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/tags?post=5567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}